Arch Biopartners Eulerpool News

Arch Biopartners Eulerpool News

Arch Biopartners Notizie Azioni

Arch Biopartners è seguito da molti giornalisti e investitori in tutto il mondo. Qui raccogliamo le più recenti notizie Arch Biopartners.

• 16 ottobre ·

  Yahoo
  Arch Biopartners Arranges Non-Brokered Private Placement
• 3 ottobre ·

  Yahoo
  Closes Units for Debt Settlement
• 3 ottobre ·

  Thefly.com
  Arch Biopartners closes units for debt settlement
• 26 settembre ·

  Yahoo
  Units for Debt Settlement
• 26 settembre ·

  Thefly.com
  Arch Biopartners announces units for debt settlement
• 11 settembre ·

  Yahoo
  Arch Biopartners Announces Alberta Health Services Approval to Proceed with Phase II Trial for LSALT Peptide Targeting Cardiac Surgery-Associated Acute Kidney Injury (CS-AKI)
• 5 agosto ·

  Yahoo
  Arch Biopartners’ cilastatin enters Phase II trial for AKI prevention
• 2 agosto ·

  Yahoo
  Arch Biopartners’ Cilastatin Drug Candidate to Participate in the PONTIAC Phase II Trial Targeting Acute Kidney Injury Caused by Drug Toxins
• 2 agosto ·

  GlobeNewswire
  Arch Biopartners? Cilastatin Drug Candidate to Participate in the PONTIAC Phase II Trial Targeting Acute Kidney Injury Caused by Drug Toxins
• 2 agosto ·

  Thefly.com
  Arch Biopartners announces cilastatin to participate in PONTIAC Phase II trial